Acacia Pharma Group
News & analysis
Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Acacia Pharma Group PLC is a biopharmaceutical company that focuses on developing and commercializing novel products to improve the care of patients undergoing medical treatments such as surgery, invasive procedures, or chemotherapy. Its product portfolio includes BARHEMSYS, BYFAVO, and APD403.Acacia Pharma Group PLC is a pharmaceutical company, focused on the development and commercialization of hospital products for U.S and international markets to treat and prevent nausea and vomiting suffered by surgical and cancer patients.
Latest ACPH News